Didier Renard

2.4k total citations
42 papers, 1.7k citations indexed

About

Didier Renard is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Management Science and Operations Research. According to data from OpenAlex, Didier Renard has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Statistics and Probability, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Management Science and Operations Research. Recurrent topics in Didier Renard's work include Statistical Methods in Clinical Trials (19 papers), Advanced Causal Inference Techniques (8 papers) and Statistical Methods and Bayesian Inference (7 papers). Didier Renard is often cited by papers focused on Statistical Methods in Clinical Trials (19 papers), Advanced Causal Inference Techniques (8 papers) and Statistical Methods and Bayesian Inference (7 papers). Didier Renard collaborates with scholars based in Belgium, United States and Switzerland. Didier Renard's co-authors include Geert Molenberghs, Helena Geys, Tomasz Burzykowski, Marc Buyse, Philip J. Lowe, Tony Vangeneugden, Annouschka Laenen, Joke Denekens, Paul Van Royen and B. Michiels and has published in prestigious journals such as Journal of the American College of Cardiology, Biometrics and CHEST Journal.

In The Last Decade

Didier Renard

40 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Didier Renard 633 336 310 177 168 42 1.7k
Gene Pennello 278 0.4× 161 0.5× 133 0.4× 98 0.6× 39 0.2× 48 1.4k
Gregory W. Daniel 138 0.2× 343 1.0× 65 0.2× 137 0.8× 51 0.3× 46 1.5k
Spencer Phillips Hey 282 0.4× 479 1.4× 124 0.4× 228 1.3× 194 1.2× 68 1.5k
Pascale Tubert‐Bitter 206 0.3× 122 0.4× 220 0.7× 189 1.1× 60 0.4× 70 1.8k
Aurélien Latouche 444 0.7× 253 0.8× 225 0.7× 338 1.9× 105 0.6× 62 2.2k
Mario Ouwens 242 0.4× 210 0.6× 187 0.6× 171 1.0× 46 0.3× 67 904
Erica Brittain 615 1.0× 217 0.6× 67 0.2× 151 0.9× 329 2.0× 59 2.3k
Takashi Sozu 231 0.4× 104 0.3× 133 0.4× 163 0.9× 85 0.5× 88 1.4k
Danielle Burke 215 0.3× 147 0.4× 572 1.8× 143 0.8× 125 0.7× 35 2.5k
Philip Jarvis 247 0.4× 142 0.4× 112 0.4× 86 0.5× 163 1.0× 30 1.6k

Countries citing papers authored by Didier Renard

Since Specialization
Citations

This map shows the geographic impact of Didier Renard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Renard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Renard more than expected).

Fields of papers citing papers by Didier Renard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Renard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Renard. The network helps show where Didier Renard may publish in the future.

Co-authorship network of co-authors of Didier Renard

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Renard. A scholar is included among the top collaborators of Didier Renard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Renard. Didier Renard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terranova, Nadia, Didier Renard, Mohamed H. Shahin, et al.. (2023). Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices. Clinical Pharmacology & Therapeutics. 115(4). 658–672. 40 indexed citations
2.
Mochel, Jonathan P., Bryan F. Burkey, Martin Fink, et al.. (2014). FIRST-IN-CLASS ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696 MODULATES THE DYNAMICS OF THE RENIN CASCADE AND NATRIURETIC PEPTIDES SYSTEM WITH SIGNIFICANT REDUCTION OF ALDOSTERONE EXPOSURE. Journal of the American College of Cardiology. 63(12). A806–A806. 3 indexed citations
3.
Rowe, Steven M., Heather Hathorne, Didier Renard, et al.. (2013). Reduced Sodium Transport With Nasal Administration of the Prostasin Inhibitor Camostat in Subjects With Cystic Fibrosis. CHEST Journal. 144(1). 200–207. 26 indexed citations
4.
Overend, Tim, Didier Renard, M.R.J. Gibbs, et al.. (2012). A novel model-based approach for dose determination of glycopyrronium bromide in COPD. BMC Pulmonary Medicine. 12(1). 74–74. 30 indexed citations
5.
Holland‐Letz, Tim, Holger Dette, & Didier Renard. (2011). Efficient Algorithms for Optimal Designs with Correlated Observations in Pharmacokinetics and Dose‐Finding Studies. Biometrics. 68(1). 138–145. 6 indexed citations
6.
7.
Séchaud, Romain, et al.. (2011). Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD). International Journal of Clinical Pharmacology and Therapeutics. 50(2). 118–128. 28 indexed citations
8.
Lowe, Philip J. & Didier Renard. (2011). Omalizumab decreases IgE production in patients with allergic (IgE‐mediated) asthma; PKPD analysis of a biomarker, total IgE. British Journal of Clinical Pharmacology. 72(2). 306–320. 97 indexed citations
9.
Renard, Didier, Michael Looby, Benjamin Krämer, et al.. (2011). Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches. Respiratory Research. 12(1). 54–54. 36 indexed citations
10.
Wilens, Timothy E., Lenard A. Adler, Margaret D. Weiss, et al.. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug and Alcohol Dependence. 96(1-2). 145–154. 128 indexed citations
11.
Eilers, Paul H.C., et al.. (2007). Joint detection of important biomarkers and optimal dose–response model using penalties. Statistics in Medicine. 26(27). 4876–4888. 3 indexed citations
12.
Vangeneugden, Tony, Annouschka Laenen, Helena Geys, Didier Renard, & Geert Molenberghs. (2005). Applying Concepts of Generalizability Theory on Clinical Trial Data to Investigate Sources of Variation and Their Impact on Reliability. Biometrics. 61(1). 295–304. 93 indexed citations
13.
Nguti, Rosemary, et al.. (2005). Joint modelling of repeated measurements and event time: Application to performance traits and survival of lambs bred in sub-humid tropics. Genetics Selection Evolution. 37(3). 175–97. 4 indexed citations
14.
Vangeneugden, Tony, Annouschka Laenen, Helena Geys, Didier Renard, & Geert Molenberghs. (2004). Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements. Controlled Clinical Trials. 25(1). 13–30. 60 indexed citations
15.
Alonso, Ariel, Geert Molenberghs, Tomasz Burzykowski, et al.. (2004). Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints. Biometrics. 60(3). 724–728. 46 indexed citations
16.
Speybroeck, Niko, Frank Boelaert, Didier Renard, et al.. (2003). Design-based analysis of surveys: a bovine herpesvirus 1 case study. Epidemiology and Infection. 131(2). 991–1002. 10 indexed citations
17.
Renard, Didier, Liesbeth Bruckers, Geert Molenberghs, Akke Vellinga, & Pierre Van Damme. (2001). Repeated‐measures models to evaluate a hepatitis B vaccination programme. Statistics in Medicine. 20(6). 951–963. 8 indexed citations
18.
Burzykowski, Tomasz, Geert Molenberghs, Marc Buyse, Helena Geys, & Didier Renard. (2001). Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points. Journal of the Royal Statistical Society Series C (Applied Statistics). 50(4). 405–422. 150 indexed citations
19.
Buyse, Marc, Geert Molenberghs, Tomasz Burzykowski, Didier Renard, & Helena Geys. (2000). The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics. 1(1). 49–67. 428 indexed citations
20.
Hendrikx, Marc, et al.. (1999). Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. Journal of Thoracic and Cardiovascular Surgery. 118(3). 452–459. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gene Pennello Breakdown of academic impact, for papers by Gregory W. Daniel Breakdown of academic impact, for papers by Spencer Phillips Hey Breakdown of academic impact, for papers by Pascale Tubert‐Bitter Breakdown of academic impact, for papers by Aurélien Latouche Breakdown of academic impact, for papers by Mario Ouwens Breakdown of academic impact, for papers by Erica Brittain Breakdown of academic impact, for papers by Takashi Sozu Breakdown of academic impact, for papers by Danielle Burke Breakdown of academic impact, for papers by Philip Jarvis
Rankless by CCL
2026